In certain rat and APP transgenic mouse models of Alzheimer’s disease, for example, specific effector CD4+ T cells secreting IFN-γ, IL-17 or IL-22 were linked to increased neuroinflammation and exacerbation of disease progression [59, 60]. The gene discussed is APP; the disease is Alzheimer disease.